Calusterone

• Catalog No.: DB01564
• CAS Number: 17021-26-0
• M. F.: C21H32O2
• M. W.: 316.47758

SYNONYMS

• IUPAC name: (1S,2R,9S,10R,11S,14S,15S)-14-hydroxy-2,9,14,15-tetramethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
• IUPAC Traditional name: calusterone
• Brand Name: Methosarb
• Synonyms: Calusteron; 17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one; CLS; 7-beta,17-alpha-Dimethyl testosterone; Calusterona [inn-spanish]; Calusteronum [inn-latin]; 17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one; 17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one; 7-beta,17-Dimethyltestosterone; 7beta,17-Dimethyltestosterone; 7beta,17alpha-Dimethyltestosterone

DATABASE IDS

• CAS Number: 17021-26-0
• PubChem SID: 46507441
• PubChem CID: 28204

DETAILS

Description (English)

• Drug Groups: illicit; experimental
• Description: A 17-alkylated orally active androgenic steroid. A Schedule IV drug in Canada.
• Indication: An anabolic steroid which can theoretically aid in restauration and buildup of certain tissues, especially muscle. It is similar to synthetic testosterone and is still in early investigation. It was also investigated for use as a treatment for metastatic breast cancer.
• Pharmacology: Calusterone is a 17-alkylated orally active androgenic steroid. Calusterone may alter the metabolism of estradiol and reduce estrogen production. Calusterone has been investigated for possible antitumor properties.
• Affected Organisms: Humans and other mammals
• References: Meli RJ, Ros PR: MR appearance of intra-abdominal metastatic melanoma. Magn Reson Imaging. 1992;10(4):705-8. [Pubmed]

REFERENCES

• Meli RJ, Ros PR: MR appearance of intra-abdominal metastatic melanoma. Magn Reson Imaging. 1992;10(4):705-8. Pubmed